Clarithromycin

• Echec-MAT - A combination of antibiotics to improve neonatal mortality and morbidity for pregnancies complicated with previable labour and i… Pending
  2023-505500-37-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• CLARITHROMYCIN TO PREVENT SECONDARY INFECTIONS IN PATIENTS WITH SEPSIS FOLLOWING LOWER RESPIRATORY TRACT INFECTIONS: THE CLASSIFY TRIAL Pending
  2025-525058-20-00 Phase III 1 country Elliniko Institouto Meletis Tis Sipsis
• A Study to Evaluate a New Treatment Option for Helicobacter pylori Infection Compared to First Line Treatment. Recruiting
  2026-525291-26-00 Phase III 1 country Verisfield Single Member S.A.
• Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting
  2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
• Biomarker-Guided Early Clarithromycin Treatment To Prevent Sepsis Progression In Community-Acquired Pneumonia: The REACT Randomized Clinical… Recruiting
  2023-507295-40-00 Phase III 1 country Hellenic Institute For The Study Of Sepsis
• Finding the best treatment for lung disease from infection with Mycobacterium abscessus Recruiting
  2023-506575-99-00 Phase II 1 country The University Of Queensland
• CLAZI : CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective co… Recruiting
  2024-518578-15-00 Phase III 1 country Centre Hospitalier Universitaire Amiens Picardie
• Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended
  2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht

Showing 1–8 of 8 trials